Sorry, this entry is only available in Ukrainian and Russian.
Оголошено переможців Всесвітньої премії в галузі дженериків та біосимілярів 2023 року
Вас может заинтересовать:
WEB only
Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…
WEB only
The participation will allow specialists of the leading national pharmaceutical manufacturer to improve the competencies necessary for the production of drugs based on RNA technology. The project is implemented within…
